Concepedia

Joseph J. Senn

JJ

15

Publications

4.8K

Citations

15

H-Index

2001

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Medical University of South Carolina

University of Rochester

Alnylam Pharmaceuticals (United States)

Millennium Engineering and Integration (United States)

Joseph J. Senn is an author at Moderna Therapeutics (United States) specializing in cell biology, medicine, and cell signaling.

Top concepts

Publications per year

2001–2019

15

Publications

15

Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes

Joseph J. Senn, Peter Klover, Irena Nowak et al. · Diabetes · 2002 · 868 citations · Full text

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines

Kimberly J. Hassett, Kerry E. Benenato, Eric Jacquinet et al. · Molecular Therapy — Nucleic Acids · 2019 · 841 citations · Full text

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Staci Sabnis, E. Sathyajith Kumarasinghe, Timothy Salerno et al. · Molecular Therapy · 2018 · 753 citations · Full text

Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes

Joseph J. Senn, Peter Klover, Irena Nowak et al. · Journal of Biological Chemistry · 2003 · 608 citations · Full text

, , +20

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Robert Feldman, Rainard Fuhr, Igor Smolenov et al. · Vaccine · 2019 · 453 citations · Full text

Rows per page

1–5 of 15